CD1530 is a selective RARgamma agonist with an Kd of 150 nM[1]. CD1530 has been used in combination with bexarotene to inhibit oral carcinogenesis induced by the carcinogen 4-nitroquinoline 1-oxide in a mouse model of human oral-cavity and esophageal squamou
Molecular Weight:
398.49
Purity:
98.13
CAS Number:
[107430-66-0]
Formula:
C27H26O3
Target:
RAR/RXR
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted